Aytu BioScience expands MiOXSYS distribution network in Europe

Aytu BioScience expands MiOXSYS distribution network in Europe

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced an exclusive... Read More

Friday July 14, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS, GryNumber Health

Aytu BioScience sells Primsol to Allegis Holdings

Aytu BioScience sells Primsol to Allegis Holdings

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced the divestiture of... Read More

Tuesday April 4, 2017 0 comments Tags: Englewood, Aytu BioScience, Allegis Holdings, Josh Disbrow, Natesto, MiOXSYS

Aytu BioScience launches Asian distribution network for MiOXSYS fertility drug

Aytu BioScience launches Asian distribution network for MiOXSYS fertility drug

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced it entered into... Read More

Friday December 16, 2016 0 comments Tags: Englewood, Aytu BioScience, MiOXSYS, Josh Disbrow

Aytu BioScience announces study demonstrating utility of male infertility product

Aytu BioScience announces study demonstrating utility of male infertility product

ENGLEWOOD -- Aytu BioScience, Inc .(OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the publication... Read More

Thursday July 21, 2016 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS

Aytu BioScience announces European distribution for MiOXSYS infertility drug

Aytu BioScience announces European distribution for MiOXSYS infertility drug

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced it has entered... Read More

Tuesday June 14, 2016 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS

Aytu BioScience study demonstrates expanded utility of MiOXSYS for assessing oxidative stress as male infertility marker

Aytu BioScience study demonstrates expanded utility of MiOXSYS for assessing oxidative stress as male infertility marker

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced new clinical... Read More

Tuesday May 10, 2016 0 comments Tags: Englewood, Aytu BioScience, Ashok Agarwal, Josh Disbrow, MiOXSYS

Aytu BioScience offering 18.75M shares to raise $7.5M

Aytu BioScience offering 18.75M shares to raise $7.5M

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on commercializing novel products in the field of urology, today announced it has priced an... Read More

Tuesday May 3, 2016 0 comments Tags: Aytu BioScience, Englewood, Natesto, MiOXSYS, ProstaScint, Primsol

Aytu BioScience awarded Health Canada approval for its MiOXSYS™ system for male infertility

Aytu BioScience awarded Health Canada approval for its MiOXSYS™ system for male infertility

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on global commercialization of novel products in the field of urology, announced it has... Read More

Wednesday April 6, 2016 0 comments Tags: Englewood, Josh Disbrow, Aytu BioScience, MiOXSYS